<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
SCHEDULE 13D
UNDER SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 8)
Food Technology Service, Inc.
(formerly Vindicator, Inc.)
--------------------------------------------------------------------------------
(Name of Issuer)
Common Shares, $0.01 Par Value
--------------------------------------------------------------------------------
(Title of Class of Securities)
927341107
--------------------------------------------------------------------------------
(CUSIP Number)
David L. Nicholds, Esq.
MDS Nordion Inc.
447 March Road
Kanata, Ontario, Canada K2K 1X8
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
September 13, 2000
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement
If the filing person has previously filed a statement on Schedule 13D to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box. [ ]
Check the following box if a fee is being paid with the statement [ ]. (A fee is
not required only if the reporting person: (1) has a pervious statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
<PAGE> 2
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-1(a) for other parties to whom copies are to be
sent.
The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purposes of Section 13 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE> 3
CUSIP NO. 927341107 SCHEDULE 13D PAGE 1 OF 5 PAGES
--------------------- ----- -----
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MDS Nordion Inc. (formerly Nordion International Inc.)
---------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
---------------------------------------------------------------------
(3)
---------------------------------------------------------------------
(4) SOURCE OF FUNDS*
WC & Affiliate
---------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED 2(d) OR [ ]
PURSUANT TO ITEMS 2(e) [ ]
---------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
Ontario, Canada
---------------------------------------------------------------------
(7) SOLE VOTING POWER
NUMBER OF
SHARES --------------------------------------------------------
BENEFICIALLY (8) SHARED VOTING POWER
OWNED BY 5,944,872
EACH --------------------------------------------------------
REPORTING (9) SOLE DISPOSITIVE POWER
PERSON WITH
--------------------------------------------------------
(10) SHARED DISPOSITIVE POWER
5,944,872
--------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,944,872
---------------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
---------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
54.94%
---------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
CO
---------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 4
CUSIP NO. 927341107 SCHEDULE 13D PAGE 2 OF 5 PAGES
--------------------- ----- -----
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Laboratoires MDS Quebec Ltee
---------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
---------------------------------------------------------------------
(3)
---------------------------------------------------------------------
(4) SOURCE OF FUNDS*
WC & Affiliate
---------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED 2(d) OR [ ]
PURSUANT TO ITEMS 2(e) [ ]
---------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
Ontario, Canada
---------------------------------------------------------------------
(7) SOLE VOTING POWER
NUMBER OF
SHARES --------------------------------------------------------
BENEFICIALLY (8) SHARED VOTING POWER
OWNED BY 5,944,872
EACH --------------------------------------------------------
REPORTING (9) SOLE DISPOSITIVE POWER
PERSON WITH
--------------------------------------------------------
(10) SHARED DISPOSITIVE POWER
5,944,872
--------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,944,872
---------------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
---------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
54.94%
---------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
CO
---------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 5
CUSIP NO. 927341107 SCHEDULE 13D PAGE 3 OF 5 PAGES
--------------------- ----- -----
(1) NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MDS INC.
---------------------------------------------------------------------
(2) CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [ ]
---------------------------------------------------------------------
(3)
---------------------------------------------------------------------
(4) SOURCE OF FUNDS*
WC & Affiliate
---------------------------------------------------------------------
(5) CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED 2(d) OR [ ]
PURSUANT TO ITEMS 2(e) [ ]
---------------------------------------------------------------------
(6) CITIZENSHIP OR PLACE OF ORGANIZATION
Ontario, Canada
---------------------------------------------------------------------
(7) SOLE VOTING POWER
NUMBER OF
SHARES --------------------------------------------------------
BENEFICIALLY (8) SHARED VOTING POWER
OWNED BY 5,944,872
EACH --------------------------------------------------------
REPORTING (9) SOLE DISPOSITIVE POWER
PERSON WITH
--------------------------------------------------------
(10) SHARED DISPOSITIVE POWER
5,944,872
--------------------------------------------------------
(11) AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,944,872
---------------------------------------------------------------------
(12) CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
---------------------------------------------------------------------
(13) PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
54.94%
---------------------------------------------------------------------
(14) TYPE OF REPORTING PERSON*
CO
---------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> 6
Item 1. SECURITY AND ISSUER.
Shares of Common Stock, $0.01 par value
Food Technology Service, Inc.
502 Prairie Mine Road
Mulberry, Florida 33860 USA
Item 2. IDENTITY AND BACKGROUND
N/A
Item 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
N/A
Item 4. PURPOSE OF TRANSACTION
Item 4 is hereby amended.
As confirmed by letter Agreement dated May 18, 2000
(previously filed) Food Technology Service, Inc.'s ("FTSI")
indebtedness to MDS Nordion Inc. ("Nordion") as at February 4,
2000 is in the amount of $963,194 (the "Debt"). The Debt is
convertible into shares at the conversion rate of 70% of the
closing price, on the last trade date, prior to the exercise
of the conversion right. Additionally, such Letter Agreement
provides that the right of conversion of interest on the Debt
accruing from February 5, 2000 to January 1, 2001, into shares
of FTSI, has been waived by Nordion. The drop in FTSI's share
price has given rise to an increase in the number of shares,
to which Nordion would be beneficially entitled if it
exercised its right of conversion of the Debt. Since the 13D
Amendment 7, filed with the SEC on June 26, 2000, (which
computed the amount of beneficially owned shares based on the
closing share price on June 26, 2000 i.e., 70% of $4.25 or
$2.975) the closing share price of FTSI on September 13, 2000
decreased to $2.81. Seventy percent (70%) thereof corresponds
to a conversion price of $1.968.
At the close of business on September 13, 2000, Nordion
beneficially owned 5,944,872 shares of stock, which
constitutes approximately 54.94% of the outstanding shares of
FTSI. The number of shares beneficially owned as of September
13, 2000 has been computed by aggregating (i) the number of
shares that Nordion actually owns; and (ii) the number of
shares into which Nordion could elect to convert the remaining
outstanding Debt on the basis of the closing price of
September 13, 2000 (i.e., 70% of $2.8125 or $1.968). As a
result of the transaction, the number of shares beneficially
owned by Nordion increased by 165,666 shares. Pursuant to
publicly available information 10,331,201 shares of Food
Technology Service, Inc. were issued and outstanding on
September 13, 2000.
Item 5. INTEREST IN SECURITIES OF THE ISSUER
See Item 4.
Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDING OR RELATIONSHIPS
WITH RESPECT TO SECURITIES OF THE ISSUER.
See item 4.
<PAGE> 7
Item 7. MATERIALS TO BE FILED AS EXHIBITS
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief
the undersigned certify that the information set forth in this statement is true
and correct.
Dated: September 20, 2000
MDS NORDION INC.,
By: /s/ David L. Nicholds
-----------------------------------------------
Name: David L. Nicholds
Title: Vice President, General Counsel
MDS INC.,
By: /s/ Peter E. Brent
-----------------------------------------------
Name: Peter E. Brent
Title: Senior Vice President & General Counsel
LABORATOIRES MDS QUEBEC LTEE.
By: /s/ Peter E. Brent
-----------------------------------------------
Name: Peter E. Brent
Title: Vice President & Corporate Secretary
